• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameINDERMIL TISSUE ADHESIVE
Classification Nametissue adhesive for the topical approximation of skin
Generic Nametissue adhesive
Regulation Number878.4010
ApplicantCOVIDIEN LP, FORMERLY REGISTERED AS UNITED STATES
PMA NumberP010002
Supplement NumberS004
Date Received05/19/2003
Decision Date11/12/2003
Product Code
MPN[ Registered Establishments with MPN ]
Advisory Committee General & Plastic Surgery
Supplement Typereal-time process
Supplement Reason labeling change - instructions
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the addition of a cannula to the applicator and a microbial barrier claim to the labeling. The device, as modified, will be marketed under the trade name indermil. Tissue adhesive and is indicated for the closure of topical skin incisions including laparoscopic skin incisions, and trauma-induced lacerations in areas of low skin tension that are simple, thoroughly-cleansed, and have easily approximated skin edges. In vitro studies have also shown that indermil may act as a barrier to microbial penetration when the adhesive film remains unbroken. Indermil tissue adhesive may be used in conjunction with, but not in place of, deep dermal stitches.
-
-